Kestra Medical Technologies
KMTS
73 hedge funds and large institutions have $785M invested in Kestra Medical Technologies in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 25 increasing their positions, 8 reducing their positions, and 19 closing their positions.
213% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 8
58% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 19
16% more funds holding
Funds holding: 63 → 73 (+10)
1.73% more ownership
Funds ownership: 90.53% → 92.26% (+1.7%)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
30% less capital invested
Capital invested by funds: $1.12B → $785M (-$332M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$17.4M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$15.8M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$12.6M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$10.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$21.2M |
| 2 |
Millennium Management
New York
|
-$8.91M |
| 3 |
O
OrbiMed
New York
|
-$6.23M |
| 4 |
PA
Perceptive Advisors
New York
|
-$4.98M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$3.61M |
KMTS Hedge Fund Activity: Q2 2025 in Review
73 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Kestra Medical Technologies (KMTS) for Q2 2025, worth a combined $785M — down 30% from $1.12B a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new KMTS positions and 19 closed out — a net gain of 11 holders — while 25 added to existing stakes and 8 trimmed.
The largest buyer was BlackRock, adding an estimated $17.4M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $21.2M.
- 73 institutional investors held Kestra Medical Technologies (KMTS) as of Q2 2025, up from 63 in Q1 2025.
- Funds reported $785M of Kestra Medical Technologies stock for Q2 2025, down 30% quarter-over-quarter.
- 30 funds opened new Kestra Medical Technologies positions in Q2 2025 and 19 closed out, a net change of +11 holders.
- The largest Kestra Medical Technologies buyer in Q2 2025 was BlackRock, an estimated $17.4M added.
- The largest Kestra Medical Technologies seller in Q2 2025 was T. Rowe Price Investment Management, an estimated $21.2M sold.
Based on aggregated 13F filings for Q2 2025.